Publication | Closed Access

A novel self-assembled epitope peptide nanoemulsion vaccine targeting nasal mucosal epithelial cell for reinvigorating CD8+ T cell immune activity and inhibiting tumor progression

VaccinationNovel Self-assembled EpitopeMucosal VaccinationNanoemulsion VaccineImmunoengineeringImmunologyTumor ProgressionTherapeutic VaccineImmunoeditingT Cell ImmunityVaccine DesignImmunotherapyMedicineCell BiologySynthetic Immunology